Expert consensus decision pathway developed for patients currently taking statins and needing additional treatment
Dapagliflozin Cuts CV Risk in Heart Failure With Preserved LVEF
Risk reduced for primary outcome of worsening heart failure or cardiovascular death
Acetazolamide Helps Treat Volume Overload in Heart Failure
Rate of successful decongestion higher with addition of acetazolamide to loop diuretic in patients with acute decompensated heart failure
Device-Measured Physical Activity Tied to Heart Failure Risk
Risk reduced for 150 to 300 min/week of moderate-intensity physical activity and for 75 to 150 min/week vigorous-intensity physical activity
Any Type of Leisure-Time Physical Activity Tied to Lower Mortality Risk
However, diminishing returns seen for high levels across leisure activities for older adults
Cholesterol Concentrations Improved in U.S. Adults From 2007 to 2018
Among adults taking statins, rates of lipid control lower for women versus men, Blacks and other Hispanics versus Whites
Women Receptive to Smart Wearable Technology During Pregnancy
Most women would wear electrocardiogram technology for increased fetal health monitoring
Religion/Spirituality Tied to Better CV Health in African Americans
Odds of achieving cardiovascular health according to Life’s Simple 7 indicators increased with higher levels of religiosity/spirituality
USPSTF Recommends Statins for Primary Prevention of CVD in Adults
Statin use recommended for adults aged 40 to 75 years with at least one CVD risk factor and estimated 10-year CVD event risk of ≥10 percent
Small CV Impact Seen When Replacing Salt With Low-Sodium Salt Substitute
The small effects of LSSS versus regular salt on cardiovascular health in adults may be important when implemented at the population level